USA – Pfizer/BioNTech: COVID-19 vaccine protects against variant

"It is an important step to further confirm the strong efficacy and good safety data we have seen so far," BioNTech CEO Uğur Şahin said.

Pfizer and BioNTech said Thursday that trials suggest that their vaccine is effective against a coronavirus variant that first emerged in South Africa, which some experts worry might evade existing shots.

The drugmakers also said in a statement that 12,000 people involved in their Phase 3 trial experienced high levels of protection against Covid-19 six months after their second doses, with no serious safety concerns.

« It is an important step to further confirm the strong efficacy and good safety data we have seen so far, » said Uğur Şahin, CEO and co-founder of BioNTech…